ConductScience.org, home

Paper · 36079015

Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection.

Shatila M and 1 other. J Clin Med, 2022. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection. Papers, record 36079015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36079015

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection.
PubMed
Journal
J Clin Med
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
2.63
iCite
Revised in PubMed
2023-03-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shatila MMalekhttps://orcid.org/0000-0001-8503-7811
2Thomas ASAnusha Shirwaikar

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References157

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134,352,253Advances in diagnosis of Helicobacter pylori through biosensors: Point of care devices.Anal Biochem2021https://conductscience.org/library/papers/34352253PubMed
226,935,876Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.Gut2016https://conductscience.org/library/papers/26935876PubMed
335,509,128Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis.Am J Gastroenterol2022https://conductscience.org/library/papers/35509128PubMed
432,167,605Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection.J Gastroenterol Hepatol2020https://conductscience.org/library/papers/32167605PubMed
533,405,435Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg).J Clin Gastroenterol2022https://conductscience.org/library/papers/33405435PubMed
628,771,198Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond.Int J Mol Sci2017https://conductscience.org/library/papers/28771198PubMed
721,890,816Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.Gut2012https://conductscience.org/library/papers/21890816PubMed
824,359,515Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the ¹³C-Urea breath test.BMC Public Health2013https://conductscience.org/library/papers/24359515PubMed
912,144,575One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.Aliment Pharmacol Ther2002https://conductscience.org/library/papers/12144575PubMed
1019,816,567MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy.PLoS Pathog2009https://conductscience.org/library/papers/19816567PubMed

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42,903,391Comparison of Non-invasive Diagnostic Methods for Helicobacter Pylori Infection Before and After Treatment.Middle East J Dig Dis2026https://conductscience.org/library/papers/42903391PubMed
42,485,399Structure-guided identification of a potential inhibitor targeting the VacA toxin of Helicobacter pylori.PLoS One2026https://conductscience.org/library/papers/42485399PubMed
41,777,417Prevalence and factors associated with helicobacter pylori positivity among patients with gastritis in an endemic region of Pakistan.SAGE Open Med2026https://conductscience.org/library/papers/41777417PubMed
41,606,475Predicting clinical outcomes in Helicobacter pylori-positive patients using supervised learning through the integration of demographic and genomic features.BMC Gastroenterol2026https://conductscience.org/library/papers/41606475PubMed
41,530,488Platelets/lymphocytes ratio and neutrophils/lymphocytes ratio in children with H. pylori associated gastritis: a canary in the mine?Pediatr Res2026https://conductscience.org/library/papers/41530488PubMed
41,406,108The relationship between dietary intake of B vitamins and H. pylori seropositivity.PLoS One2025https://conductscience.org/library/papers/41406108PubMed
40,225,981Risk factors and prediction model for rebleeding in grade IIb peptic ulcer patients after endoscopy.Am J Transl Res2025https://conductscience.org/library/papers/40225981PubMed
40,177,490Efficacy and safety of vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for patients with Helicobacter pylori infection: a meta-analysis.Front Microbiol2025https://conductscience.org/library/papers/40177490PubMed
40,082,850Effect of Helicobacter pylori infection on survival outcomes of patients undergoing radical gastrectomy after neoadjuvant chemotherapy: a multicenter study in China.BMC Cancer2025https://conductscience.org/library/papers/40082850PubMed
38,818,466Association of oxidative balance score with helicobacter pylori infection and mortality in the US population.Int J Med Sci2024https://conductscience.org/library/papers/38818466PubMed

1 to 10 of 19

See all 19 cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36079015

GET https://conductscience.org/api/papers/v1/36079015/references?page=2